一脉阳光今日盘中股价大幅上涨5.31%，引起了市场的广泛关注。
消息面上，公司于早间发布公告，拟通过全资子公司以总代价约3.53亿港元收购两家目标公司的全部股权。交易完成后，一脉阳光对专注于医学影像人工智能的企业“影禾医脉”的直接及间接持股比例将提升至约25.36%。此次增持被视为公司完善“数据-模型-场景”战略布局、夯实AI技术底层能力的关键举措，市场预期这将强化其在医学影像AI领域的核心竞争力与长期增长潜力。
根据公告，本次收购代价将以发行新股及转让库存股的方式支付。影禾医脉作为一家医学影像AI大模型企业，其技术能力与一脉阳光全国影像中心运营优势的结合，有望构建数据驱动与技术赋能的双向循环，共同打造行业壁垒。此举显著增强了投资者对公司未来发展的信心，从而推动了股价在交易时段内的强劲表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.